FAZIO, VITO MICHELE
FAZIO, VITO MICHELE
FARMACOLOGIA TRASLAZIONALE - IFT
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity
2024 Cioce, M.; Arbitrio, M.; Polera, N.; Altomare, E.; Rizzuto, A.; De Marco, C.; Fazio, V. M.; Viglietto, G.; Lucibello, M.
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma
2021 Cioce, Mario; Canino, Claudia; Pass, Harvey; Blandino, Giovanni; Strano, Sabrina; Fazio, VITO MICHELE
Epha2 and egfr: Friends in life, partners in crime. can epha2 be a predictive biomarker of response to anti-egfr agents?
2021 Cioce M.; Fazio V.M.
Insights into intra-tumoral heterogeneity: Transcriptional profiling of chemoresistant mpm cell subpopulations reveals involvement of nfkb and dna repair pathways and contributes a prognostic signature
2021 Cioce M.; Sacconi A.; Pass H.I.; Canino C.; Strano S.; Blandino G.; Fazio V.M.
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
2020 Cioce M.; Pulito C.; Strano S.; Blandino G.; Fazio V.M.
Enhancing plasmid nuclear import and delivery system: room for improvement
2013 Fioretti, D.; Iurescia, S.; Fazio, V. M.; Rinaldi, M.
In Vivo DNA Electrotransfer for Immunotherapy of Cancer And Neurodegenerative Diseases.
2013 Fioretti, D; Iurescia, S; Fazio, Vm; Rinaldi, M.
Plasmid vector design and technologies for DNA vaccine development
2013 Iurescia, S.; Fioretti, D.; Pierimarchi, P.; Signori, E.; Zonfrillo, M.; Fazio, V. M.; Rinaldi, M.
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge
2012 Iurescia, Sandra; Fioretti, Daniela; Fazio, VITO MICHELE; Rinaldi, Monica
Application of electroporation in DNA vaccination protocols.
2010 Chiarella P.,; Fazio V.M.; Signori E.,
DNA vaccination strategies for anti-tumour effective gene therapy protocols
2010 Signori, E; Iurescia, S; Massi, E; Fioretti, D; Chiarella, P; De Robertis, M; Rinaldi, M; Tonon, G; Fazio, Vm
DNA vaccines: developing new strategies against cancer
2010 Fioretti, D.; Iurescia, S.; Fazio, V. M.; Rinaldi, M.
Strategies for Effective Naked-DNA Vaccination
2010 Chiarella, P; Massi, E; De Robertis, M; Fazio, Vm; Signori, E
Recent advances in epitope design for immunotherapy of cancer
2009 Chiarella P.; Massi E.; De Robertis M.; Fazio V.M.; Signori E.
Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration.
2008 Chiarella P.; Massi E.; De Robertis M.; Sibilio A.; Parrella P; Fazio V.M.; Signori E.
Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases.
2008 Chiarella, P; Massi, E; De Robertis, M; Fazio, Vm; Signori, E
Adjuvants in vaccines and for immunisation: current trends.
2007 Chiarella, P; Massi, E; De Robertis, M; Signori, E; Fazio, Vm
ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice.
2007 Signori E.; Rinaldi M.; Fioretti D.; Iurescia S.; Seripa D.; Perrone G.; Norata G.D.; Catapano A.L.; Fazio V.M.;
CDR3-targeted DNA vaccines in B-cell lymphoma
2007 Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Tonon, G; Fazio, Vm
DNA Vaccine Strategy against chronic B-cell lymphoma: anti-idiotypic CDR3 vaccination.
2007 Iurescia, S; Fioretti, D; Signori, E; Pierimarchi, P; Tonon, G; Fazio, Vm; Rinaldi, M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity | 1-gen-2024 | Cioce, M.; Arbitrio, M.; Polera, N.; Altomare, E.; Rizzuto, A.; De Marco, C.; Fazio, V. M.; Viglietto, G.; Lucibello, M. | |
Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma | 1-gen-2021 | Cioce, Mario; Canino, Claudia; Pass, Harvey; Blandino, Giovanni; Strano, Sabrina; Fazio, VITO MICHELE | |
Epha2 and egfr: Friends in life, partners in crime. can epha2 be a predictive biomarker of response to anti-egfr agents? | 1-gen-2021 | Cioce M.; Fazio V.M. | |
Insights into intra-tumoral heterogeneity: Transcriptional profiling of chemoresistant mpm cell subpopulations reveals involvement of nfkb and dna repair pathways and contributes a prognostic signature | 1-gen-2021 | Cioce M.; Sacconi A.; Pass H.I.; Canino C.; Strano S.; Blandino G.; Fazio V.M. | |
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity | 1-gen-2020 | Cioce M.; Pulito C.; Strano S.; Blandino G.; Fazio V.M. | |
Enhancing plasmid nuclear import and delivery system: room for improvement | 1-gen-2013 | Fioretti, D.; Iurescia, S.; Fazio, V. M.; Rinaldi, M. | |
In Vivo DNA Electrotransfer for Immunotherapy of Cancer And Neurodegenerative Diseases. | 1-gen-2013 | Fioretti, D; Iurescia, S; Fazio, Vm; Rinaldi, M. | |
Plasmid vector design and technologies for DNA vaccine development | 1-gen-2013 | Iurescia, S.; Fioretti, D.; Pierimarchi, P.; Signori, E.; Zonfrillo, M.; Fazio, V. M.; Rinaldi, M. | |
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge | 1-gen-2012 | Iurescia, Sandra; Fioretti, Daniela; Fazio, VITO MICHELE; Rinaldi, Monica | |
Application of electroporation in DNA vaccination protocols. | 1-gen-2010 | Chiarella P.,; Fazio V.M.; Signori E., | |
DNA vaccination strategies for anti-tumour effective gene therapy protocols | 1-gen-2010 | Signori, E; Iurescia, S; Massi, E; Fioretti, D; Chiarella, P; De Robertis, M; Rinaldi, M; Tonon, G; Fazio, Vm | |
DNA vaccines: developing new strategies against cancer | 1-gen-2010 | Fioretti, D.; Iurescia, S.; Fazio, V. M.; Rinaldi, M. | |
Strategies for Effective Naked-DNA Vaccination | 1-gen-2010 | Chiarella, P; Massi, E; De Robertis, M; Fazio, Vm; Signori, E | |
Recent advances in epitope design for immunotherapy of cancer | 1-gen-2009 | Chiarella P.; Massi E.; De Robertis M.; Fazio V.M.; Signori E. | |
Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. | 1-gen-2008 | Chiarella P.; Massi E.; De Robertis M.; Sibilio A.; Parrella P; Fazio V.M.; Signori E. | |
Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases. | 1-gen-2008 | Chiarella, P; Massi, E; De Robertis, M; Fazio, Vm; Signori, E | |
Adjuvants in vaccines and for immunisation: current trends. | 1-gen-2007 | Chiarella, P; Massi, E; De Robertis, M; Signori, E; Fazio, Vm | |
ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice. | 1-gen-2007 | Signori E.; Rinaldi M.; Fioretti D.; Iurescia S.; Seripa D.; Perrone G.; Norata G.D.; Catapano A.L.; Fazio V.M.; | |
CDR3-targeted DNA vaccines in B-cell lymphoma | 1-gen-2007 | Rinaldi, M; Iurescia, S; Fioretti, D; Signori, E; Tonon, G; Fazio, Vm | |
DNA Vaccine Strategy against chronic B-cell lymphoma: anti-idiotypic CDR3 vaccination. | 1-gen-2007 | Iurescia, S; Fioretti, D; Signori, E; Pierimarchi, P; Tonon, G; Fazio, Vm; Rinaldi, M |